Canalevia® (crofelemer delayed-release tablets), under the name Canalevia®-CA1, is conditionally approved by the FDA for treatment of CID in dogsCompany…
All financial results are reported in Canadian dollars unless otherwise stated.Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - Numinus…
neurocare's Apollo TMS Therapy systems are now FDA-cleared for the treatment of Obsessive Compulsive Disorder, offering a new non-drug treatment…
MARLTON, N.J., Aug. 20, 2025 /PRNewswire/ -- Tribe Intensive NJ, a premier dual-diagnosis addiction treatment provider offering both partial hospitalization…
The Investment is part of BrainsWay’s ongoing strategy to acquire minority positions in leading U.S. mental health providers to help…
BRIDGEPORT, Conn., Aug. 19, 2025 /PRNewswire/ -- University of Bridgeport's (UB) master's in Clinical Mental Health Counseling program is entering…
Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to…
After a successful pilot, Dismas Charities partners with The Change Companies to bring individualized, digital-first programming to justice-involved individuals. CARSON…
MOUNTAIN VIEW, Calif., Aug. 19, 2025 /PRNewswire/ -- JustPaid, the AI-powered revenue automation platform backed by Y Combinator, today announced…
Combining intelligent tools and personalized support, RethinkCare empowers employers, families and caregivers with clinically validated resources, expert coaching and navigation…